Unique ID issued by UMIN | UMIN000002137 |
---|---|
Receipt number | R000002555 |
Scientific Title | PhaseI/II trial of neoadjvant chemoradiotherapy with docetaxel,CDDP and 5-Fluorouracil followed by surgery in patients with advanced esophageal cancer. |
Date of disclosure of the study information | 2009/08/01 |
Last modified on | 2020/03/19 16:24:08 |
PhaseI/II trial of neoadjvant chemoradiotherapy with docetaxel,CDDP and 5-Fluorouracil followed by surgery in patients with advanced esophageal cancer.
PhaseI/II trial of neoadjvant chemoradiotherapy with DCF in patients with advanced esophageal cancer.
PhaseI/II trial of neoadjvant chemoradiotherapy with docetaxel,CDDP and 5-Fluorouracil followed by surgery in patients with advanced esophageal cancer.
PhaseI/II trial of neoadjvant chemoradiotherapy with DCF in patients with advanced esophageal cancer.
Japan |
Esophageal Cancer
Gastrointestinal surgery | Radiology |
Malignancy
NO
Phase I part: to evaluate maximum tolerated dose and dose-limiting toxicities to determine recommended dose of docetaxel in combination with a fixed dose of cisplatin and 5-FU and radiotherapy follwed by surgery in patients with advanesd esophageal cancer.
Phase II part: to evaluate the efficacy and safety of neoadjuvant chemoradiotherapy with docetaxel, cisplatin and 5-FU follwed by surgery in patients with advanced esophageal cancer.
Safety,Efficacy
Exploratory
Phase I,II
PhaseI:Incidence of dose limiting toxicity
PhaseII:Histopathological response rate
PhaseI:Adverse events,Histopathological response rate
PhaseII:Adverse events, Disease-free survival, Overall survival
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine | Device,equipment | Maneuver |
Radiotherapy(2Gy/5day/week) is begun within 24 hours of the administration of chemotherapy, and continue for 4 weeks(40Gy).
Combination chemotherapy consists of docetaxel (25,30,35,40 mg/m2/day, day 1,15,29 and day 43), cisplatin (70 mg/m2/day, day 1,29), and 5-FU (700mg/m2/day, days 1 through 4 and days 29-32).
20 | years-old | <= |
75 | years-old | >= |
Male and Female
1.Histologically proven esophageal carcinoma.
2.Lesion located within the radiation field.
3.Primary lesion with penetration of muscularis propiria, excluding T4 lesion and distant metastasis.
4.Measurable lesion
5.No previous therapy against esophageal cancer.
6.No previous radiotherapy within the radiation field.
7.ECOG Performance status 0 or 1
8.Aged 20 to 75 years old
9.Expected to survive more than 3 months
10.Written informed consent
1.History of hypersensitivity to DOC, CDDP, 5-FU, or polysorbate 80
2.With severe complication
3.Infection with fever elevation
4.Motor paralysis, peripheral neuropathy or edema
5.Pleural or pericardial effusion that requires treatment
6.Simultaneous or metachronous (within 5 years) double cancers.
7.Pregnant or lactating women
8.Interstitial pneumonia or fibroid lung
9.Psychosis
40
1st name | Morihito |
Middle name | |
Last name | Okada |
Research Institute for Radiation Biology and Medicine Hirosima University
Surgical Oncology
734-8551
1-2-3, Kasumi, Minami-ku, Hiroshima city, Hiroshima 734-8551 Japan
082-257-5869
morihito1217@gmail.com
1st name | Manabu |
Middle name | |
Last name | Emi |
Research Institute for Radiation Biology and Medicine Hirosima University
Surgical Oncology
734-8551
1-2-3, Kasumi, Minami-ku, Hiroshima city, Hiroshima 734-8551 Japan
082-257-5869
moaista@hotmail.com
Department of Surgical Oncology, Division of Clinical and Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University
Department of Surgical Oncology, Division of Clinical and Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University
Self funding
Hiroshima University hospital Center of Integrated Medical Research
Kasumi 1-2-3, Minami-Ku, Hiroshima 734-8553, Japan
082-257-1752
protocol@cimr.hiroshima-u.ac.jp
NO
2009 | Year | 08 | Month | 01 | Day |
Unpublished
Completed
2009 | Year | 06 | Month | 01 | Day |
2009 | Year | 09 | Month | 07 | Day |
2009 | Year | 08 | Month | 01 | Day |
2014 | Year | 11 | Month | 01 | Day |
2009 | Year | 06 | Month | 29 | Day |
2020 | Year | 03 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002555
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |